130 related articles for article (PubMed ID: 9354198)
21. Effect of proton pump inhibitors on the secretion of bicarbonates and pepsinogen induced by chemical stimulation of the gastric mucosa.
Zolotarev VA; Khropycheva RP
Bull Exp Biol Med; 2013 Feb; 154(4):415-8. PubMed ID: 23486568
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and pharmacological characteristics of a newly synthesized H+/K+-ATPase inhibitor, YJA20379-8, 3-butyryl-4-[R-1-methylbenzylamino]-8-ethoxy-1,7-naphthyridine, in pigs and rats.
Sohn SK; Chang MS; Choi WS; Chung YK; Kim KB; Woo TW; Lee SB; Park CJ
J Pharm Pharmacol; 1999 Dec; 51(12):1359-65. PubMed ID: 10678489
[TBL] [Abstract][Full Text] [Related]
23. Aspirin-like drugs, ethanol-induced rat gastric injury and mucosal eicosanoid release.
Trautmann M; Peskar BM; Peskar BA
Eur J Pharmacol; 1991 Aug; 201(1):53-8. PubMed ID: 1794414
[TBL] [Abstract][Full Text] [Related]
24. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
Fukuda T; Arakawa T; Shimizu Y; Ohtani K; Higuchi K; Kobayashi K
J Clin Gastroenterol; 1995; 20 Suppl 2():S5-7. PubMed ID: 7594340
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 2000 Jun; 51(2):179-92. PubMed ID: 10898092
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
27. Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats.
Tashima K; Fujita A; Umeda M; Takeuchi K
Life Sci; 2000 Aug; 67(13):1639-52. PubMed ID: 10983857
[TBL] [Abstract][Full Text] [Related]
28. Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen.
Gund M; Gaikwad P; Borhade N; Burhan A; Desai DC; Sharma A; Dhiman M; Patil M; Sheikh J; Thakre G; Tipparam SG; Sharma S; Nemmani KVS; Satyam A
Bioorg Med Chem Lett; 2014 Dec; 24(24):5587-5592. PubMed ID: 25466180
[TBL] [Abstract][Full Text] [Related]
29. Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.
Tanaka S; Akiba Y; Kaunitz JD
Gut; 1998 Sep; 43(3):334-41. PubMed ID: 9863477
[TBL] [Abstract][Full Text] [Related]
30. A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.
Takayama S; Izuhara C; Yamada N; Yamanaka S; Hashimoto E; Kaneko S; Takeuchi K
J Physiol Pharmacol; 2012 Feb; 63(1):41-52. PubMed ID: 22460460
[TBL] [Abstract][Full Text] [Related]
31. Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
Berenguer B; Alarcón de la Lastra C; Moreno FJ; Martín MJ
Eur J Pharmacol; 2002 May; 442(1-2):125-35. PubMed ID: 12020690
[TBL] [Abstract][Full Text] [Related]
32. Age-related reductions in gastric mucosal prostaglandin levels increase susceptibility to aspirin-induced injury in rats.
Lee M; Feldman M
Gastroenterology; 1994 Dec; 107(6):1746-50. PubMed ID: 7958687
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
34. Importance of gastric acid in gastric ulcer formation in rabbits with antibody-induced prostaglandin deficiency.
Lee M; Aldred K; Lee E; Prince MD; Feldman M
Gastroenterology; 1992 Nov; 103(5):1467-74. PubMed ID: 1426865
[TBL] [Abstract][Full Text] [Related]
35. Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin?
Fernández-Fernández FJ
Arch Intern Med; 2002 Oct; 162(19):2248. PubMed ID: 12390073
[No Abstract] [Full Text] [Related]
36. Effect of experimental spinal cord injury on salicylate bioavailability after oral aspirin administration.
Fuentes-Lara G; Guízar-Sahagún G; García-López P
J Pharmacol Toxicol Methods; 1999 Oct; 42(2):93-7. PubMed ID: 10924892
[TBL] [Abstract][Full Text] [Related]
37. Interaction of omeprazole with enteric-coated salicylate tablets.
Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
[TBL] [Abstract][Full Text] [Related]
38. Influence of gastric acid secretion blockade and food intake on the bioavailability of a potassium diclofenac suspension in healthy male volunteers.
Poli A; Moreno RA; Ribeiro W; Dias HB; Moreno H; Muscara MN; De Nucci G
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):76-9. PubMed ID: 8929750
[TBL] [Abstract][Full Text] [Related]
39. Role of nitric oxide in pathogenesis of aspirin-induced gastric mucosal damage in rats.
Takeuchi K; Yasuhiro T; Asada Y; Sugawa Y
Digestion; 1998; 59(4):298-307. PubMed ID: 9693199
[TBL] [Abstract][Full Text] [Related]
40. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
